adplus-dvertising
Connect with us

Investment

The Best Stocks to Invest $5,000 in Right Now – The Motley Fool

Published

 on


Some investors might be tempted to chase momentum and buy the highest-flying stocks around. Others could be worried about the stock market’s nosebleed valuation and avoid stocks altogether. I think there’s a middle-of-the-road strategy that’s better than either of those approaches.

Instead of chasing unsustainable momentum, find stocks that are poised to deliver exceptional long-term gains. And rather than staying away from the market because of valuation, find stocks that are bargains. 

With those two goals in mind, here are my picks for the best stocks to invest $5,000 in right now.

1. Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX 0.18%) hasn’t skyrocketed 50% or more as some stocks have so far in 2023. However, the biotech stock nonetheless has a good head of steam going with a year-to-date gain of nearly 25%. More importantly, I think Vertex has plenty of room to run.

The company is awaiting regulatory approvals in the U.S. and Europe for exa-cel in treating sickle cell disease and transfusion-dependent beta-thalassemia. The gene-editing therapy seems likely to become Vertex’s first blockbuster outside of its core focus area of cystic fibrosis (CF).

More highly promising drugs could also be on the way. Vertex anticipates three other launches over the next five years. The company could have its most powerful CF therapy yet with its vanzacaftor triple-drug combo. Non-opioid pain drug VX-548 could have tremendous commercial potential. Inaxaplin targets APOL1-mediated kidney disease, an indication that affects more patients than CF.

But is Vertex ridiculously expensive? Not at all. Its shares trade at a price-to-earnings-to-growth (PEG) ratio of only 0.58. Any PEG multiple below 1.0 is considered to be an attractive valuation.

2. Brookfield Renewable

Brookfield Renewable Partners (BEP 1.42%) and Brookfield Renewable Corporation (BEPC 2.01%)stand out as other stocks that have delivered a solid albeit not spectacular performance so far this year. Brookfield Renewable Partners, a limited partnership (LP), trades under the BEP ticker while Brookfield Renewable Corporation, which has a corporate structure that avoids the tax hassles associated with an LP, trades under the BEPC ticker. They are up about 18% so far this year.

Both stocks have the same underlying business. And it’s a great business. Brookfield Renewable operates hydroelectric, wind, solar, and distributed energy facilities across the world.

The company expects to deliver total annual returns of between 12% and 15% over the long run. This goal seems quite attainable considering the likelihood of strong demand for renewable energy over the coming decades.

At first glance, Brookfield Renewable might not seem like much of a bargain with shares trading at forward earnings multiples of 26. But with the growth the renewable energy provider is poised to generate, that valuation actually looks really attractive.

3. U.S. Bancorp

Unlike Vertex and Brookfield Renewable, U.S. Bancorp (USB -1.84%) hasn’t been a winner for shareholders so far this year. Its stock has fallen by 11% while the overall market has soared.

Bank failures earlier in 2023 caused a banking crisis that clobbered U.S. Bancorp’s share price. While the stock has bounced back considerably from its lows, it still hasn’t fully recovered. I expect that it will, though.

U.S. Bancorp weathered the Federal Reserve’s annual stress test well. CEO Andy Cecere said in June that the test showed that the bank is “well-capitalized and remain[s] prepared to withstand a severe economic downturn.” The company also delivered solid second-quarter results

There are a couple of positive effects of U.S. Bancorp’s big sell-off. Its dividend yield was pushed higher and now stands at nearly 5.2%. The stock is also dirt cheap, trading at below 8.4 times earnings estimates.

Keith Speights has positions in Brookfield Renewable, Brookfield Renewable Partners, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Brookfield Renewable and Vertex Pharmaceuticals. The Motley Fool recommends Brookfield Renewable Partners and U.S. Bancorp. The Motley Fool has a disclosure policy.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Economy

S&P/TSX composite down more than 200 points, U.S. stock markets also fall

Published

 on

 

TORONTO – Canada’s main stock index was down more than 200 points in late-morning trading, weighed down by losses in the technology, base metal and energy sectors, while U.S. stock markets also fell.

The S&P/TSX composite index was down 239.24 points at 22,749.04.

In New York, the Dow Jones industrial average was down 312.36 points at 40,443.39. The S&P 500 index was down 80.94 points at 5,422.47, while the Nasdaq composite was down 380.17 points at 16,747.49.

The Canadian dollar traded for 73.80 cents US compared with 74.00 cents US on Thursday.

The October crude oil contract was down US$1.07 at US$68.08 per barrel and the October natural gas contract was up less than a penny at US$2.26 per mmBTU.

The December gold contract was down US$2.10 at US$2,541.00 an ounce and the December copper contract was down four cents at US$4.10 a pound.

This report by The Canadian Press was first published Sept. 6, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX composite up more than 150 points, U.S. stock markets also higher

Published

 on

 

TORONTO – Canada’s main stock index was up more than 150 points in late-morning trading, helped by strength in technology, financial and energy stocks, while U.S. stock markets also pushed higher.

The S&P/TSX composite index was up 171.41 points at 23,298.39.

In New York, the Dow Jones industrial average was up 278.37 points at 41,369.79. The S&P 500 index was up 38.17 points at 5,630.35, while the Nasdaq composite was up 177.15 points at 17,733.18.

The Canadian dollar traded for 74.19 cents US compared with 74.23 cents US on Wednesday.

The October crude oil contract was up US$1.75 at US$76.27 per barrel and the October natural gas contract was up less than a penny at US$2.10 per mmBTU.

The December gold contract was up US$18.70 at US$2,556.50 an ounce and the December copper contract was down less than a penny at US$4.22 a pound.

This report by The Canadian Press was first published Aug. 29, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Investment

Crypto Market Bloodbath Amid Broader Economic Concerns

Published

 on

Breaking Business News Canada

The crypto market has recently experienced a significant downturn, mirroring broader risk asset sell-offs. Over the past week, Bitcoin’s price dropped by 24%, reaching $53,000, while Ethereum plummeted nearly a third to $2,340. Major altcoins also suffered, with Cardano down 27.7%, Solana 36.2%, Dogecoin 34.6%, XRP 23.1%, Shiba Inu 30.1%, and BNB 25.7%.

The severe downturn in the crypto market appears to be part of a broader flight to safety, triggered by disappointing economic data. A worse-than-expected unemployment report on Friday marked the beginning of a technical recession, as defined by the Sahm Rule. This rule identifies a recession when the three-month average unemployment rate rises by at least half a percentage point from its lowest point in the past year.

Friday’s figures met this threshold, signaling an abrupt economic downshift. Consequently, investors sought safer assets, leading to declines in major stock indices: the S&P 500 dropped 2%, the Nasdaq 2.5%, and the Dow 1.5%. This trend continued into Monday with further sell-offs overseas.

The crypto market’s rapid decline raises questions about its role as either a speculative asset or a hedge against inflation and recession. Despite hopes that crypto could act as a risk hedge, the recent crash suggests it remains a speculative investment.

Since the downturn, the crypto market has seen its largest three-day sell-off in nearly a year, losing over $500 billion in market value. According to CoinGlass data, this bloodbath wiped out more than $1 billion in leveraged positions within the last 24 hours, including $365 million in Bitcoin and $348 million in Ether.

Khushboo Khullar of Lightning Ventures, speaking to Bloomberg, argued that the crypto sell-off is part of a broader liquidity panic as traders rush to cover margin calls. Khullar views this as a temporary sell-off, presenting a potential buying opportunity.

Josh Gilbert, an eToro market analyst, supports Khullar’s perspective, suggesting that the expected Federal Reserve rate cuts could benefit crypto assets. “Crypto assets have sold off, but many investors will see an opportunity. We see Federal Reserve rate cuts, which are now likely to come sharper than expected, as hugely positive for crypto assets,” Gilbert told Coindesk.

Despite the recent volatility, crypto continues to make strides toward mainstream acceptance. Notably, Morgan Stanley will allow its advisors to offer Bitcoin ETFs starting Wednesday. This follows more than half a year after the introduction of the first Bitcoin ETF. The investment bank will enable over 15,000 of its financial advisors to sell BlackRock’s IBIT and Fidelity’s FBTC. This move is seen as a significant step toward the “mainstreamization” of crypto, given the lengthy regulatory and company processes in major investment banks.

The recent crypto market downturn highlights its volatility and the broader economic concerns affecting all risk assets. While some analysts see the current situation as a temporary sell-off and a buying opportunity, others caution against the speculative nature of crypto. As the market evolves, its role as a mainstream alternative asset continues to grow, marked by increasing institutional acceptance and new investment opportunities.

Continue Reading

Trending